Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Josh Donaldson"'
Autor:
Phil Oravetz, Christopher J White, David Carmouche, Nicole Swan, Josh Donaldson, Russel Ruhl, Czarlota Valdenor, David Paculdo, Mary Tran, John Peabody
Publikováno v:
Open Heart, Vol 6, Iss 1 (2019)
Objective Low quality and unwarranted clinical variation harm patients and increase unnecessary costs. Effective approaches to improve clinical and economic value have been difficult. The Ochsner Health System looked to improve clinical care quality
Externí odkaz:
https://doaj.org/article/95753c2514e1409b9708b19ccb0a0896
Autor:
Daniel J. Zabransky, David Chu, Tasha Hunter, Lauren Dennison, Cody Ramin, Richard B.S. Roden, Karen Cravero, Swathi Karthikeyan, W. Brian Dalton, Kelly Kyker-Snowman, Berry Button, Ian Waters, D. Marc Rosen, Betty J. May, Eric S. Christenson, Ben Ho Park, Dana Petry, Kala Visvanathan, Sarah Croessmann, Josh Donaldson, Deborah K. Armstrong
Publikováno v:
Breast Cancer Research and Treatment. 174:401-412
PURPOSE: Estrogen receptor-alpha (ER) is a therapeutic target of ER positive (ER+) breast cancers. Although ER signaling is complex, many mediators of this pathway have been identified. Specifically, phosphorylation of ER at serine 118 affects respon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e4c34d039e6cb5743610567294942d2
https://doi.org/10.1007/s10549-018-05087-7
https://doi.org/10.1007/s10549-018-05087-7
Autor:
Swathi Karthikeyan, Josh Donaldson, David Marc Rosen, Kelly Kyker-Snowman, Konstantinos Konstantopoulos, Sarah Croessmann, Karen Cravero, Robert M. Hughes, Paula J. Hurley, Berry Button, Eric S. Christenson, Natasha Hunter, Christopher L. Yankaskas, Lauren Dennison, Ian Waters, Ben Ho Park
Publikováno v:
Breast Cancer Res Treat
BACKGROUND/PURPOSE: TrkA overexpression occurs in over 20% of breast cancers, including triple-negative breast cancers (TNBC), and has recently been recognized as a potential driver of carcinogenesis. Recent clinical trials of pan-Trk inhibitors have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2627c03475462a339bb27d327864a0f
https://europepmc.org/articles/PMC7337566/
https://europepmc.org/articles/PMC7337566/
Autor:
David Carmouche, Josh Donaldson, Christopher J. White, David Paculdo, Czarlota Valdenor, Phil Oravetz, Russel Ruhl, Mary Tran, Nicole Swan, John W. Peabody
Publikováno v:
Open Heart
ObjectiveLow quality and unwarranted clinical variation harm patients and increase unnecessary costs. Effective approaches to improve clinical and economic value have been difficult. The Ochsner Health System looked to improve clinical care quality a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77c732b9d158b61d0301c62d637c8ade
https://pubmed.ncbi.nlm.nih.gov/30997137
https://pubmed.ncbi.nlm.nih.gov/30997137
Autor:
Arielle Medford, Daniel Shinn, Josh Donaldson, Daniel J. Zabransky, Amy E. DeZern, Anil Magugundu, Noel Walsh, Josh Lauring, Alexander P. Cole, Taylor Groginski, Arun H. Patil, Karen Cravero, Ben Park, William Brian Dalton, Natasha B. Hunter, Eric S. Christenson, Justin Lee, David Chu, Akhilesh Pandey, Dhanashree S. Kelkar
Publikováno v:
Cancer Research. 78:1408-1408
Mutations in the SF3B1 gene occur in multiple cancers, creating a neomorphic spliceosome protein that induces aberrant mRNA splicing in thousands of genes. Little is known about the downstream oncogenic or therapeutic consequences of this missplicing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::378e3a55dab3e4a9354b7a46477d9c1f
https://doi.org/10.1158/1538-7445.am2018-1408
https://doi.org/10.1158/1538-7445.am2018-1408